期刊文献+
共找到24篇文章
< 1 2 >
每页显示 20 50 100
Perspective of future drugs targeting sterile 20/SPS1-related proline/alanine-rich kinase for blood pressure control
1
作者 Gen-Min Lin Pang-Yen Liu +2 位作者 Ching-Fen Wu Wen-Been Wang Chih-Lu Han 《World Journal of Cardiology》 CAS 2015年第6期306-310,共5页
According to a genome-wide association study,intronic SNPs within the human sterile 20/SPS1-related proline/alanine-rich kinase(SPAK) gene was linked to 20% of the general population and may be associated with elevate... According to a genome-wide association study,intronic SNPs within the human sterile 20/SPS1-related proline/alanine-rich kinase(SPAK) gene was linked to 20% of the general population and may be associated with elevated blood pressure. As cell volume changes,mammalian SPAK kinases respond to phosphorylate and regulate cation-coupled chloride co-transporter activity. To our knowledge,phosphorylation of upstream with-no-lysine(K)(WNK) kinases would activate SPAK kinases. The activation of WNK-OSR1/SPAK cascade on the kidneys and aortic tissue is related to the development of hypertension. Several regulators of the WNK pathway such as the Kelch kinase protein 3-Cullin 3 E3 ligase,hyperinsulinemia,and low potassium intake to mediate hypertension have been identified. In addition,the SPAK kinases may affect the action of renin-angiotensin-aldosterone system on blood pressure as well. In 2010,two SPAK knock-in and knock-out mouse models have clarified the pathogenesis of lowering blood pressure by influencing the receptors on the kidneys and aortic smooth muscle. More recently,two novel SPAK inhibitors for mice,Stock 1S-14279 and Closantel were discovered in 2014. Targeting of SPAK seems to be promising for future antihypertensive therapy. Therefore we raised some viewpoints for the issue for the antihypertensive therapy on the SPAK(gene or kinase). 展开更多
关键词 With-no-lysine(K) kinase Oxidative stressresponsive kinase 1/SPS1-related proline/alaninerich kinase kinase Na-Cl co-transporter Na+-K+-2Cl(-) COTRANSPORTER Hypertension
下载PDF
与14-3-3ζ相互作用的蛋白Polo样激酶1的筛选与鉴定
2
作者 都建 程里 +2 位作者 陈立建 陈滢 安然 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第8期804-807,共4页
目的:应用酵母双杂交系统筛选与14-3-3ζ相互作用的蛋白,进一步鉴定其与Polo样激酶1(Plk1)相互作用。方法:构建pGBKT7-14-3-3ζ诱饵表达载体,筛选HeLa细胞cDNA文库中与14-3-3ζ相互作用蛋白,进一步通过共转酵母、免疫荧光以及外源性和... 目的:应用酵母双杂交系统筛选与14-3-3ζ相互作用的蛋白,进一步鉴定其与Polo样激酶1(Plk1)相互作用。方法:构建pGBKT7-14-3-3ζ诱饵表达载体,筛选HeLa细胞cDNA文库中与14-3-3ζ相互作用蛋白,进一步通过共转酵母、免疫荧光以及外源性和内源性的细胞免疫共沉淀实验验证两者的相互作用。结果:通过酵母双杂交系统筛选出的阳性相互作用蛋白中包括Plk1,进一步通过共转酵母,外源性和内源性的细胞免疫共沉淀实验证实两者的相互作用,免疫荧光实验证实两者共定位于有丝分裂过程中胞质分裂期的中体。结论:Plk1是高度保守的丝氨酸/苏氨酸蛋白激酶,在中体的成熟,有丝分裂期染色体的分离,胞质分裂以及DNA的损伤应答等环节发挥重要作用,其与14-3-3ζ的相互作用为14-3-3蛋白家族参与有丝分裂(M期)的调控提供了直接证据。 展开更多
关键词 14-3-3蛋白 polo样激酶1 酵母双杂交 蛋白质相互作用 有丝分裂
下载PDF
Neuroprotective effects of exogenous brain-derived neurotrophic factor on amyloid-beta 1-40-induced retinal degeneration 被引量:2
3
作者 Mohd Aizuddin Mohd Lazaldin Igor Iezhitsa +2 位作者 Renu Agarwal Puneet Agarwal Nafeeza Mohd Ismail 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第2期382-388,共7页
Amyloid-beta(Aβ)-related alterations,similar to those found in the brains of patients with Alzheimer's disease,have been observed in the retina of patients with glaucoma.Decreased levels of brain-derived neurotro... Amyloid-beta(Aβ)-related alterations,similar to those found in the brains of patients with Alzheimer's disease,have been observed in the retina of patients with glaucoma.Decreased levels of brain-derived neurotrophic factor(BDNF)are believed to be associated with the neurotoxic effects of Aβpeptide.To investigate the mechanism underlying the neuroprotective effects of BDNF on Aβ_(1-40)-induced retinal injury in Sprague-Dawley rats,we treated rats by intravitreal administration of phosphate-buffered saline(control),Aβ_(1-40)(5 nM),or Aβ_(1-40)(5 nM)combined with BDNF(1μg/mL).We found that intravitreal administration of Aβ_(1-40)induced retinal ganglion cell apoptosis.Fluoro-Gold staining showed a significantly lower number of retinal ganglion cells in the Aβ_(1-40)group than in the control and BDNF groups.In the Aβ_(1-40)group,low number of RGCs was associated with increased caspase-3 expression and reduced TrkB and ERK1/2 expression.BDNF abolished Aβ_(1-40)-induced increase in the expression of caspase-3 at the gene and protein levels in the retina and upregulated TrkB and ERK1/2 expression.These findings suggest that treatment with BDNF prevents RGC apoptosis induced by Aβ_(1-40)by activating the BDNF-TrkB signaling pathway in rats. 展开更多
关键词 amyloid-beta 1-40 brain-derived neurotrophic factor FLUORO-GOLD neuroprotection retinal ganglion cells(RGC) retinal toxicity tropomyosin receptor kinase B(TrkB)
下载PDF
靶向polo样激酶-1基因小干扰RNA质粒的构建及其效能检测
4
作者 倪侃 陈佳慧 +3 位作者 贾乃昕 吴龙祥 常仁安 陈钟 《南通大学学报(医学版)》 2012年第3期183-184,F0002,共3页
目的:用脂质体法构建polo样激酶-1(polo-like kinase-1,PLK1)基因RNA(siRNA)。方法 :设计合成PLK1siRNA干扰序列,构建干扰载体,然后以该siRNA转染SMMC-7721细胞后,以实时定量Western Blot检测各组细胞PLK1蛋白表达情况。结果:应用靶向P... 目的:用脂质体法构建polo样激酶-1(polo-like kinase-1,PLK1)基因RNA(siRNA)。方法 :设计合成PLK1siRNA干扰序列,构建干扰载体,然后以该siRNA转染SMMC-7721细胞后,以实时定量Western Blot检测各组细胞PLK1蛋白表达情况。结果:应用靶向PLK1的siRNA转染SMMC-7721细胞48 h后,PLK1蛋白的表达siRNA分别较无关对照组和空白对照组有明显下降。结论:通过脂质体转染法成功构建靶向PLK1的siRNA,实现了细胞的稳定转染,为进一步研究奠定了基础。 展开更多
关键词 肝细胞性肝癌 polo样激酶-1 小干扰RNA
下载PDF
Effects of tyrosine kinase inhibitor E7080 and eNOS inhibitor L-NIO on colorectal cancer alone and in combination 被引量:4
5
作者 Ahmet Altun Tijen Kaya Temiz +2 位作者 Ezgi Balc Zübeyde Ak n Polat Mustafa Turan 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2013年第5期572-584,共13页
Objective:To investigate the effects of E7080 and N5-(1-iminoethyl)-L-ornithine dihydrochloride (L-NIO)on colorectal cancer alone and in combination.Methods:HT29 colorectal cancer cell line from Sap Institute wa... Objective:To investigate the effects of E7080 and N5-(1-iminoethyl)-L-ornithine dihydrochloride (L-NIO)on colorectal cancer alone and in combination.Methods:HT29 colorectal cancer cell line from Sap Institute was used.Real-time cell analysis (xCELLigence system) was performed to determine the effects of E7080 and L-NIO on colorectal cell proliferation.While apoptosis was determined with Annexin V staining,and the effect of agents on angiogenesis was determined with chorioallantoic membrane (CAM) model.Results:We found that E7080 has a strong antiproliferative effect with an half maximum inhibition of concentration (IC50) value of 5.60×10-8 mol/L.Also it has been observed that E7080 showed antiangiogenic and apoptotic effects on HT29 colorectal cancer cells.Antiangiogenic scores of E7080 were 1.2,t.0 and 0.6 for 100,10 and 1 nmol/L E7080 concentrations,respectively.Furthermore,apoptosis has been detected in 71% of HT29 colorectal cancer cells after administration of 100 nmol/L E7080 which may indicate strong apoptotic effect.Meanwhile administration of L-NIO alone did not show any effect,but the combination of E7080 with L-NIO increased the antiproliferative,antiangiogenic and apoptotic effects of E7080.Conclusions:Results of this study indicate that E7080 may be a good choice in treatment of colorectal tumors.Furthermore the increased effects of E7080 when combined with L-NIO raise the possibility to use a lower dose of E7080 and therefore avoid/minimize the side effects observed with E7080. 展开更多
关键词 E7080 N5-1-iminoethyl)-L-ornithine dihydrochloride (L-NIO) colorectal cancer xCELLigence system tyrosine kinase (TK)
下载PDF
新型2-喹诺酮类Polo样激酶1抑制剂的设计合成及分子对接研究
6
作者 王涛 彭涛 +3 位作者 温晓雪 王刚 张首国 王林 《生物技术通讯》 CAS 2019年第1期78-84,共7页
目的:设计合成新型2-喹诺酮类Polo样激酶1(Plk1)抑制剂。方法:以Plk1抑制剂ON 01910为先导化合物,利用生物电子等排原理设计一系列2-喹诺酮类衍生物,用Autodock软件将该类化合物与Plk1进行分子对接和虚拟筛选,计算结合自由能;以取代的氯... 目的:设计合成新型2-喹诺酮类Polo样激酶1(Plk1)抑制剂。方法:以Plk1抑制剂ON 01910为先导化合物,利用生物电子等排原理设计一系列2-喹诺酮类衍生物,用Autodock软件将该类化合物与Plk1进行分子对接和虚拟筛选,计算结合自由能;以取代的氯(溴)苄为起始原料,先后经巯基乙酸取代、双氧水氧化、与(对甲氧基)苯胺酰化,再经环合、水解制得目标化合物。结果:设计的化合物大多数与Plk1的结合自由能均比ON 01910的低,结合强度高、稳定性好;合成了16个2-喹诺酮类衍生物,产物结构经1H-NMR确证。结论:所得化合物中有15个为新化合物,化合物的结构设计科学合理,虚拟筛选结果良好,为后续实体筛选和化合物结构优化提供了理论依据和参考。 展开更多
关键词 polo样激酶1(Plk1)抑制剂 2-喹诺酮类衍生物 分子对接 设计合成
下载PDF
曲古菌素A联合5-FU对人胃癌SGC-7901细胞生长及其PLK1基因表达的影响 被引量:2
7
作者 程海燕 沈哲 +1 位作者 陈卫昌 严苏 《温州医学院学报》 CAS 2013年第9期591-594,共4页
目的:探讨曲古菌素A(TSA)与5-氟尿嘧啶(5-FU)对人胃癌细胞(SGC-7901细胞)生长及其Polo样激酶1(PLK1)基因表达的影响。方法:将实验设为对照组、TSA 150 ng/mL组(TSA组)、5-FU 20μg/mL组(5-FU组)、TSA 150 ng/mL+5-FU 20μg/mL组(TSA+5-F... 目的:探讨曲古菌素A(TSA)与5-氟尿嘧啶(5-FU)对人胃癌细胞(SGC-7901细胞)生长及其Polo样激酶1(PLK1)基因表达的影响。方法:将实验设为对照组、TSA 150 ng/mL组(TSA组)、5-FU 20μg/mL组(5-FU组)、TSA 150 ng/mL+5-FU 20μg/mL组(TSA+5-FU组)四组,用MTT比色法测定各组对SGC-7901细胞的生长影响,流式细胞仪分析细胞周期,RT-PCR分析SGC-7901细胞PLK1 mRNA表达,Western Blot法检测PLK1蛋白表达。结果:TSA和(或)5-FU分别作用24、48、72 h后均能抑制胃癌细胞生长,TSA+5-FU组较TSA组或5-FU组生长抑制作用显著增强,且随着药物作用时间的延长,抑制作用增强更明显;流式细胞术检测显示干预胃癌细胞48 h后,TSA+5-FU组G0/G1期比率为(85.23±2.17)%,较TSA组或5-FU组显著增多;TSA和(或)5-FU干预胃癌细胞48 h后,TSA+5-FU组较TSA组或5-FU组显著减弱PLK1基因mRNA转录及蛋白表达。结论:TSA联合5-FU干预,抑制人胃癌SGC-7901细胞生长,阻止细胞周期于G0/G1期,癌基因PLK1mRNA转录及蛋白表达减少均较TSA组或5-FU组明显。 展开更多
关键词 曲古菌素A 5-氟尿嘧啶 SGC-7901细胞 polo样激酶1 胃肿瘤
下载PDF
血管生成素-1对SW1116细胞的作用及其机制
8
作者 张继红 任立群 +2 位作者 李相军 尹丽 温春阳 《中国老年学杂志》 CAS CSCD 北大核心 2011年第1期100-102,共3页
目的探讨血管生成素-1(Angiopoietin-1,Ang-1)蛋白对无血清DMEM培养基培养的结肠癌细胞(SW 1116)存活率的影响及其与PI3-′k inase/Akt通路的关系。方法将不同浓度的Ang-1蛋白作用于SW 1116细胞,用MTT法检测细胞增殖,根据实验结果选定An... 目的探讨血管生成素-1(Angiopoietin-1,Ang-1)蛋白对无血清DMEM培养基培养的结肠癌细胞(SW 1116)存活率的影响及其与PI3-′k inase/Akt通路的关系。方法将不同浓度的Ang-1蛋白作用于SW 1116细胞,用MTT法检测细胞增殖,根据实验结果选定Ang-1蛋白的后续实验浓度,设计出SW 1116细胞增殖抑制模型,分别向该模型中加入Ang-1及LY294002,应用免疫印记法分析相关蛋白(Tie-2、PI3K、Akt)的变化。结果 Ang-1组与无血清DMEM培养基组比较,Tie-2、PI3K、Akt三种蛋白在SW 1116细胞中的表达均增强,但仅Tie-2的表达有显著差异(P<0.01),LY294002组三种蛋白的表达均减弱(P<0.01,P<0.05)。结论较低浓度(0.05 mg/L)的Ang-1蛋白在结肠癌细胞中即有抗凋亡作用,且随着浓度的增加抗凋亡作用逐渐加强,当高于0.2 mg/L时,作用逐渐减弱,其诱导凋亡的机制可能与Tie-2/PI3-′k inase/Akt调节的通路有关,应用该途径的抑制剂LY294002可抑制结肠癌细胞的生长,实现抗肿瘤作用。 展开更多
关键词 ANG-1 SW1116 增殖 TIE-2 PI3-kinase Akt LY294002
下载PDF
HO-1对SH-SY5Y细胞中α-突触核蛋白和PLK2表达影响 被引量:1
9
作者 王冉冉 宋宁 +1 位作者 姜宏 谢俊霞 《青岛大学医学院学报》 CAS 2016年第3期294-296,共3页
目的探讨血红素加氧酶-1(HO-1)对SH-SY5Y细胞中α-突触核蛋白与Polo样激酶2(PLK2)水平的影响。方法采用Western blot方法,检测转染携带HO-1基因片段质粒48h后的SH-SY5Y细胞α-突触核蛋白的表达。给予不同浓度的HO-1激动剂钴原卟啉(CoPPI... 目的探讨血红素加氧酶-1(HO-1)对SH-SY5Y细胞中α-突触核蛋白与Polo样激酶2(PLK2)水平的影响。方法采用Western blot方法,检测转染携带HO-1基因片段质粒48h后的SH-SY5Y细胞α-突触核蛋白的表达。给予不同浓度的HO-1激动剂钴原卟啉(CoPPIX)48h后,检测SH-SY5Y细胞PLK2的表达。结果高表达HO-1可降低细胞内α-突触核蛋白水平(t=2.672,P<0.05),10和25μmol/L的CoPPIX通过激活HO-1使PLK2表达上调(F=30.75,q=7.64、10.78,P<0.01)。结论 HO-1可使SH-SY5Y细胞中α-突触核蛋白表达下调,此过程可能与调控PLK2水平有关。 展开更多
关键词 血红素加氧酶-1 SH-SY5Y细胞 Α突触核蛋白 polo样激酶2
下载PDF
Geniposide, the component of the Chinese herbal formula Tongluojiunao, protects amyloid-β peptide(1–42)-mediated death of hippocampal neurons via the non-classical estrogen signaling pathway 被引量:3
10
作者 Jiao Li Feng Wang +11 位作者 Haimin Ding Chunyan Jin Jinyan Chen Yanan Zhao Xiaojing Li Wenju Chen Ping Sun Yan Tan Qi Zhang Xu Wang Angran Fan Qian Hua 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第5期474-480,共7页
Tongluojiunao (TLJN) is an herbal medicine consisting of two main components, geniposide and ginsenoside Rg1. TLJN has been shown to protect primary cultured hippocampal neurons. How-ever, its mechanism of action re... Tongluojiunao (TLJN) is an herbal medicine consisting of two main components, geniposide and ginsenoside Rg1. TLJN has been shown to protect primary cultured hippocampal neurons. How-ever, its mechanism of action remains unclear. In the present study, primary cultured hippocampal neurons treated with Aβ1-42 (10 μmol/L) signiifcantly increased the release of lactate dehydroge-nase, which was markedly reduced by TLJN (2 μL/mL), speciifcally by the component geniposide (26 μmol/L), but not ginsenoside Rg1 (2.5 μmol/L). hTe estrogen receptor inhibitor, ICI182780 (1 μmol/L), did not block TLJN-or geniposide-mediated decrease of lactate dehydrogenase under Aβ1-42-exposed conditions. However, the phosphatidyl inositol 3-kinase or mitogen-activated protein kinase pathway inhibitor, LY294002 (50 μmol/L) or U0126 (10 μmol/L), respectively blo cked the decrease of lactate dehydrogenase mediated by TLJN or geniposide. hTerefore, these results suggest that the non-classical estrogen pathway (i.e., phosphatidyl inositol 3-kinase or mitogen-activated protein kinase) is involved in the neuroprotective effect of TLJN, speciifcally its component, geniposide, against Aβ1-42-mediated cell death in primary cultured hippocampal neurons. 展开更多
关键词 nerve regeneration neurodegeneration Alzheimer's disease cell culture hippocampus neurons 1-42 estrogen signaling pathway phosphatidyl inositol 3-kinase pathway mitogen-acti- vated protein kinase pathway Tongluojiunao injection GENIPOSIDE ginsenoside Rgl NSFC grant neural regeneration
下载PDF
MiR-32-5p aggravates intestinal epithelial cell injury in pediatric enteritis induced by Helicobacter pylori 被引量:2
11
作者 Jing Feng Jian Guo +1 位作者 Jun-Ping Wang Bao-Feng Chai 《World Journal of Gastroenterology》 SCIE CAS 2019年第41期6222-6237,共16页
BACKGROUND Pediatric enteritis is one of the infectious diseases in the digestive system that causes a variety of digestive problems,including diarrhea,vomiting,and bellyache in children.Clinically,Helicobacter pylori... BACKGROUND Pediatric enteritis is one of the infectious diseases in the digestive system that causes a variety of digestive problems,including diarrhea,vomiting,and bellyache in children.Clinically,Helicobacter pylori(H.pylori)infection is one of the common factors to cause pediatric enteritis.It has been demonstrated that aberrant expression of microRNAs(miRNAs)is found in gastrointestinal diseases caused by H.pylori,and we discovered a significant increase of miR-32-5p in H.pylori-related pediatric enteritis.However,the exact role of miR-32-5p in it is still unknown.AIM To investigate the role of aberrant miR-32-5p in pediatric enteritis induced by H.pylori.METHODS MiR-32-5p expression was detected by quantitative real time-polymerase chain reaction.The biological role of miR-32-5p in H.pylori-treated intestinal epithelial cells was evaluated by Cell Counting Kit-8 assay and flow cytometry.The potential target of miR-32-5p was predicted with TargetScanHuman and verified by luciferase assay.The downstream mechanism of miR-32-5p was explored by using molecular biology methods.RESULTS We found that miR-32-5p was overexpressed in serum of H.pylori-induced pediatric enteritis.Further investigation revealed that H.pylori infection promoted the death of intestinal epithelial cells,and increased miR-32-5p expression.Moreover,miR-32-5p mimic further facilitated apoptosis and inflammatory cytokine secretion of intestinal epithelial cells.Further exploration revealed that SMAD family member 6(SMAD6)was the direct target of miR-32-5p,and SMAD6 overexpression partially rescued cell damage induced by H.pylori.The following experiments showed that miR-32-5p/SMAD6 participated in the apoptosis of intestinal epithelial cells induced by transforming growth factor-β-activated kinase 1(TAK1)-p38 activation under H.pylori infection.CONCLUSION Our work uncovered the crucial role of aberrant expression of miR-32-5p in H.pylori–related pediatric enteritis,and suggested that the TAK1-p38 pathway is involved in it. 展开更多
关键词 MiR-32-5p SMAD family member 6 TRANSFORMING growth factor-β-activated kinase 1 Apoptosis ENTERITIS HELICOBACTER PYLORI
下载PDF
抑制Polo样激酶1表达靶向DNA错配修复相关通路并抑制卵巢癌的相关研究 被引量:2
12
作者 李娟 何苗 +3 位作者 袁春兰 李红梅 邓小梅 肖雪 《中国病理生理杂志》 CAS CSCD 北大核心 2021年第5期871-878,共8页
目的:观察Polo样激酶1(PLK1)在卵巢癌(OC)细胞和组织中的表达情况,以及抑制PLK1表达对耐5-氟尿嘧啶(5-FU)的OC细胞活力和凋亡的影响。方法:在2011年4月~2018年12月的126名OC患者纳入本研究。采用免疫组化法检测PLK1在OC组织及邻近正常... 目的:观察Polo样激酶1(PLK1)在卵巢癌(OC)细胞和组织中的表达情况,以及抑制PLK1表达对耐5-氟尿嘧啶(5-FU)的OC细胞活力和凋亡的影响。方法:在2011年4月~2018年12月的126名OC患者纳入本研究。采用免疫组化法检测PLK1在OC组织及邻近正常卵巢组织中的表达水平。体外构建耐5-FU的OC细胞系(OVCAR3-5FU_(res)和SKOV3-FU_(res))。将PLK1重组质粒和PLK1-sh RNA慢病毒载体(sh-PLK1)分别转染到OVCAR3、SKOV3、OVCAR3-5FU_(res)和SKOV3-5FU_(res)细胞中。采用CCK-8法检测细胞活力;通过串联亲和纯化和质谱分析确定PLK1在OC细胞中的结合蛋白;流式细胞术检测细胞凋亡。结果:在OC细胞系中,PLK1水平显著上调(P<0.05);并且在大多数OC组织中,PLK1表达较癌旁组织显著上调(P<0.05)。Kaplan-Meier分析显示,PLK1高表达OC患者的平均存活时间显著短于PLK1低表达OC患者(P<0.001)。OC中PLK1水平的升高与FIGO分期、肿瘤分级和错配修复缺陷等临床病理特征显著相关(P<0.05)。与阴性对照细胞相比,转染sh-PLK1的细胞活力显著降低(P<0.05);而转染PLK1重组质粒的OVCAR3和SKOV3细胞的活力显著高于对照细胞。通过串联亲和纯化和质谱分析确定人Mut S蛋白同系物2(hMSH2)是PLK1在OC细胞中的结合蛋白,并且h MSH2基因敲除使sh-PLK1转染的OVCAR3-5FU_(res)细胞的凋亡率降低(P<0.01)。结论:抑制PLK1表达通过靶向h MSH2提高了OC细胞对5-FU的敏感性。 展开更多
关键词 polo样激酶1 卵巢癌 DNA错配修复 人MutS蛋白同系物2 5-氟尿嘧啶
下载PDF
Effect of DRB on the Biological Characteristics of Human Laryngeal Carcinoma Hep-2 Cell Line
13
作者 王建亭 龚树生 +3 位作者 付勇 薛秋红 陈广理 刘英鹏 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2007年第1期104-106,共3页
In order to study the effect of 5, 6-Dichloro-l-13-D-ribofuranosyl-benzimidazole (DRB) on the biological characteristics of human laryngeal carcinoma Hep-2 cell line in vitro, Hep-2 cells cultured in vitro were trea... In order to study the effect of 5, 6-Dichloro-l-13-D-ribofuranosyl-benzimidazole (DRB) on the biological characteristics of human laryngeal carcinoma Hep-2 cell line in vitro, Hep-2 cells cultured in vitro were treated with different concentrations of DRB. Changes in cell proliferation, apoptotic rate and invasiveness were detected by MTT assay, flow cytometry (FCM) and matrigel in vitro invasion assay, respectively. It was found that DRB inhibited the proliferation of Hep-2 cells in a dose- and time-dependent manner. After being treated with 0, 10, 20, 40, 80 μmmol/L DRB for 24 h, the apoptotic rate in Hep-2 cells was (0.68±0.19)%, (1.95±0.12)%, (8.51±0.26)%, (11.26±0.17)% and (14.99±0.32)%, respectively. The matrigel in vitro invasion assay revealed that DRB began to inhibit the invasion of Hep-2 cells at the concentration of 5 μmmol/L, and with the increase of DRB concentration, the inhibitory effect was enhanced. It was suggested that DRB could influence the essential biological characteristics of Hep-2 cells, inhibit Hep-2 cells proliferation, reduce invasive ability and induce apoptosis of Hep-2 cells. 展开更多
关键词 protein-serine-threonine kinases 5 6-Dichloro-1-β-D-ribofuranosyl- benzimidazole laryngeal neoplasms Hep-2 cell line
下载PDF
肺癌活检组织中Polo样激酶-1mRNA水平检测的临床意义 被引量:2
14
作者 应可净 邵方淳 +2 位作者 余碧芸 吴金民 丁佳逸 《中华检验医学杂志》 CAS CSCD 北大核心 2006年第9期813-816,共4页
目的探讨实时荧光定量-聚合酶链反应(RFQ-PCR)检测肺癌活检组织 Polo 样激酶-1(PLK1)mRNA 水平,及其与肺癌临床病理分期、分型的相关性。方法对69份肺癌、28份肺良性疾病患者的纤维支气管镜活检标本,采用 RFQ-PCR 检测 PLK1和 GAPDH 荧... 目的探讨实时荧光定量-聚合酶链反应(RFQ-PCR)检测肺癌活检组织 Polo 样激酶-1(PLK1)mRNA 水平,及其与肺癌临床病理分期、分型的相关性。方法对69份肺癌、28份肺良性疾病患者的纤维支气管镜活检标本,采用 RFQ-PCR 检测 PLK1和 GAPDH 荧光强度,并绘制曲线,计算出循环数阈值(Ct),相同组织中 PLK1和 GAPDH 的初始模板量的比值为2^(CtGAPDH-CtPLK1),同时以此值作为 PLK1 mRNA 水平的相对定量指标进行标本检测结果评价。结果肺癌组 PLK1 mRNA 水平为0.124±0.194,肺良性疾病组为0.037±0.042,两者差异有统计学意义(P=0.03)。而其在各病理类型和不同 TNM 分期之间的差异均无统计学意义(P>0.05),仅小细胞肺癌的表达水平略高(0.191±0.275)。结论 RFQ-PCR 测定纤维支气管镜活检标本中 PLK1基因表达增高与肺癌的发生存在一定关系,并且可能成为肺癌检测的一个肿瘤标志。 展开更多
关键词 肺肿瘤 核糖核酸 聚合酶链反应 polo样激酶-1
原文传递
小干扰RNA下调PLK1表达对食管腺癌细胞肿瘤生物学行为的影响
15
作者 杜媛鲲 赵永波 +3 位作者 米源 陈阁 廖海江 王雷 《中国医科大学学报》 CAS CSCD 北大核心 2018年第10期905-908,913,共5页
目的研究polo样激酶1(PLK1)表达下调对食管腺癌OE33细胞肿瘤生物学行为的影响,并探讨其相关的分子机制。方法将PLK1小干扰RNA (siRNA)和空白对照siRNA转染OE33细胞48 h,实时荧光定量PCR法检测OE33细胞PLK1 mRNA表达水平;采用Western blo... 目的研究polo样激酶1(PLK1)表达下调对食管腺癌OE33细胞肿瘤生物学行为的影响,并探讨其相关的分子机制。方法将PLK1小干扰RNA (siRNA)和空白对照siRNA转染OE33细胞48 h,实时荧光定量PCR法检测OE33细胞PLK1 mRNA表达水平;采用Western blotting检测OE33细胞中PLK1、E-cadherin、N-cadherin和C-myc蛋白的表达水平;流式细胞术检测OE33细胞周期分布;Transwell实验检测OE33细胞侵袭能力的改变。结果采用PLK1 siRNA抑制PLK1 mRNA和蛋白表达后可以下调C-myc蛋白表达,将细胞周期阻滞在G2/M期;同时可以通过减少N-cadherin蛋白表达,上调E-cadherin蛋白表达,降低细胞的侵袭能力,与空白对照siRNA组比较,差异均有统计学意义(P <0.01)。结论 PLK1在食管腺癌的生长转移中具有重要作用,敲除PLK1基因表达可抑制细胞有丝分裂和侵袭能力。 展开更多
关键词 RNA干扰 食管腺癌 polo样激酶1 细胞周期 上皮-间质转化
下载PDF
polo样激酶-1干扰质粒构建及对人肝癌SMMC-7721细胞株凋亡的影响
16
作者 倪侃 陈佳慧 +3 位作者 贾乃昕 吴龙祥 常仁安 陈钟 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第10期1914-1916,共3页
目的构建polo样激酶-1(PLK1)基因小于扰RNA(siRNA),观察其对肝癌细胞凋亡的影响。方法设计合成3个PLK1siRNA(siRNAl、siRNA2、siRNA3)干扰序列,构建干扰载体,转染人肝癌细胞株SMMC-7721,观察48h后转染效率,采用实时定量逆转... 目的构建polo样激酶-1(PLK1)基因小于扰RNA(siRNA),观察其对肝癌细胞凋亡的影响。方法设计合成3个PLK1siRNA(siRNAl、siRNA2、siRNA3)干扰序列,构建干扰载体,转染人肝癌细胞株SMMC-7721,观察48h后转染效率,采用实时定量逆转录-聚合酶链反应(RT—PCR)筛选下调PLK1mRNA效果最好的siRNA;然后选择以该siRNA转染48h的SMMC-7721细胞,分别以实时定量RT-PCR和Westernblot法检测空白组、对照组及转染组细胞中PLK1基因和蛋白表达;流式细胞仪检测细胞周期及细胞凋亡的改变。结果肝癌细胞株SMMC-7721中存在PLK1蛋白的过表达。应用靶向PLK1的siRNA转染SMMC-7721细胞48h后,PLK1mRNA相对水平siRNA2组分别较无关对照组和空白对照组下降了74%和78%,而PLK1蛋白的表达siRNA2组分别较无关对照组和空白对照组下降了83%和88%,抑制率达88%;siRNA2组中出现大量凋亡细胞,与对照组比较差异有统计学意义(P〈0.05)。结论PLK1基因在肝癌细胞增殖中具有重要的调控作用。PLK1-siRNA转染可明显抑制癌细胞增殖,诱导凋亡是其重要机制之一。 展开更多
关键词 肝细胞 polo样激酶-1 小干扰RNA
原文传递
AAZ2 induces mitochondrial-dependent apoptosis by targeting PDK1 in gastric cancer
17
作者 Yi LI Wenyan SHE +9 位作者 Xiaoran XU Yixin LIU Xinyu WANG Sheng TIAN Shiyi LI Miao WANG Chaochao YU Pan LIU Tianhe HUANG Yongchang WEI 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2023年第3期232-247,共16页
Drastic surges in intracellular reactive oxygen species(ROS)induce cell apoptosis,while most chemotherapy drugs lead to the accumulation of ROS.Here,we constructed an organic compound,arsenical N-(4-(1,3,2-dithiarsina... Drastic surges in intracellular reactive oxygen species(ROS)induce cell apoptosis,while most chemotherapy drugs lead to the accumulation of ROS.Here,we constructed an organic compound,arsenical N-(4-(1,3,2-dithiarsinan-2-yl)phenyl)acrylamide(AAZ2),which could prompt the ROS to trigger mitochondrial-dependent apoptosis in gastric cancer(GC).Mechanistically,by targeting pyruvate dehydrogenase kinase 1(PDK1),AAZ2 caused metabolism alteration and the imbalance of redox homeostasis,followed by the inhibition of phosphoinositide-3-kinase(PI3K)/protein kinase B(AKT)/mammalian target of rapamycin(mTOR)pathway and leading to the activation of B-cell lymphoma 2(Bcl2)/Bcl2-associated X(Bax)/caspase-9(Cas9)/Cas3 cascades.Importantly,our in vivo data demonstrated that AAZ2 could inhibit the growth of GC xenograft.Overall,our data suggested that AAZ2 could contribute to metabolic abnormalities,leading to mitochondrial-dependent apoptosis by targeting PDK1 in GC. 展开更多
关键词 N-(4-(1 3 2-dithiarsinan-2-yl)phenyl)acrylamide(AAZ2) Gastric cancer Reactive oxygen species(ROS) Apoptosis Pyruvate dehydrogenase kinase 1(PDK1) Glucose metabolism
原文传递
PLK1小分子抑制剂的抗肿瘤活性及其在肿瘤治疗中的应用现状 被引量:4
18
作者 张德勇 《浙江医学》 CAS 2018年第3期303-306,共4页
在肿瘤治疗中蛋白激酶被认为是重要的干预靶点之一。作为高度保守的苏氨酸、丝氨酸蛋白激酶,Polo样激酶(polo-like kinase,PLK)在真核生物中广泛存在。PLK1在多数肿瘤组织中表达均显著上调,且参与细胞恶性生物学行为及肿瘤的发生、发展... 在肿瘤治疗中蛋白激酶被认为是重要的干预靶点之一。作为高度保守的苏氨酸、丝氨酸蛋白激酶,Polo样激酶(polo-like kinase,PLK)在真核生物中广泛存在。PLK1在多数肿瘤组织中表达均显著上调,且参与细胞恶性生物学行为及肿瘤的发生、发展,所有的证据均显示PLK1在肿瘤的治疗过程中可能是重要的干预靶点。随着临床上对PLK1小分子抑制剂研究的不断深入,不断有新的PLK1高效选择性抑制剂被发现,以PLK1为靶点的肿瘤干预方案已成为肿瘤治疗中的热点。本文将对PLK1小分子抑制剂在肿瘤治疗中的应用现状及抗肿瘤活性进行综述。 展开更多
关键词 polo样激酶-1 抑制剂 抗肿瘤
下载PDF
14-3-3ε调节小鼠受精卵纺锤体组装
19
作者 崔城 秦鑫 +2 位作者 纪晓菁 杨裕鑫 于秉治 《生殖与避孕》 CAS CSCD 北大核心 2015年第5期283-288,共6页
目的:研究14-3-3ε蛋白调节小鼠受精卵纺锤体组装的作用。方法:采用间接免疫荧光实验检测1-细胞期受精卵14-3-3ε和α-微管蛋白的亚细胞定位;利用显微注射方法将14-3-3εsi RNA注射入1-细胞期受精卵,观察小鼠受精卵纺锤体形态及检测Pol... 目的:研究14-3-3ε蛋白调节小鼠受精卵纺锤体组装的作用。方法:采用间接免疫荧光实验检测1-细胞期受精卵14-3-3ε和α-微管蛋白的亚细胞定位;利用显微注射方法将14-3-3εsi RNA注射入1-细胞期受精卵,观察小鼠受精卵纺锤体形态及检测Polo样激酶1(Plk1)的活性。结果:14-3-3ε和α-微管蛋白在G1期、S期和G2期卵中主要共定位于细胞质,M期卵14-3-3ε主要位于细胞质皮质。小鼠受精卵注射14-3-3εsi RNA后导致异常形态纺锤体形成及Plk1活性下降。结论:14-3-3ε蛋白在调节小鼠受精卵纺锤体组装中发挥重要作用。 展开更多
关键词 14-3-3ε蛋白 小鼠受精卵 纺锤体组装 polo样激酶1(Plk1)
原文传递
Polo样激酶1的功能及其在肿瘤治疗中的研究进展
20
作者 潘冰 贺强 《国际外科学杂志》 2022年第9期644-648,共5页
蛋白激酶是细胞功能的关键调节分子,参与编排绝大多数细胞活动,组成了纵横交错的调节网络。调节细胞蛋白活性中起关键作用的激酶是抗癌药物的主要靶标,因为它们的异常形式可以促进肿瘤细胞的增殖。Polo样激酶-1(Plk-1)是丝氨酸/苏氨酸(S... 蛋白激酶是细胞功能的关键调节分子,参与编排绝大多数细胞活动,组成了纵横交错的调节网络。调节细胞蛋白活性中起关键作用的激酶是抗癌药物的主要靶标,因为它们的异常形式可以促进肿瘤细胞的增殖。Polo样激酶-1(Plk-1)是丝氨酸/苏氨酸(Ser/Thr)激酶polo样家族成员之一,参与调节细胞增殖的有丝分裂过程的多个方面,是真核细胞有丝分裂的关键激酶之一,它的过表达与人类许多癌症的发生发展密切相关。针对Plk-1的药物开发可能是治疗癌症的前景方向之一。本文将总结Plk-1的结构特征和参与的细胞过程,以及针对Plk-1抗肿瘤治疗的基本原理和抑制剂开发的最新进展和最新策略。 展开更多
关键词 细胞周期 肿瘤治疗方案 蛋白激酶类 polo样激酶-1 肿瘤发生 小分子抑制剂
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部